Annual Current Liabilities
$155.91 M
+$3.31 M+2.17%
December 31, 2023
Summary
- As of February 25, 2025, CTMX annual total current liabilities is $155.91 million, with the most recent change of +$3.31 million (+2.17%) on December 31, 2023.
- During the last 3 years, CTMX annual current liabilities has risen by +$87.80 million (+128.91%).
- CTMX annual current liabilities is now at all-time high.
Performance
CTMX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$119.23 M
-$23.63 M-16.54%
September 30, 2024
Summary
- As of February 25, 2025, CTMX quarterly total current liabilities is $119.23 million, with the most recent change of -$23.63 million (-16.54%) on September 30, 2024.
- Over the past year, CTMX quarterly current liabilities has dropped by -$27.56 million (-18.78%).
- CTMX quarterly current liabilities is now -23.53% below its all-time high of $155.91 million, reached on December 31, 2023.
Performance
CTMX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
CTMX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.2% | -18.8% |
| 3 y3 years | +128.9% | -18.8% |
| 5 y5 years | +59.2% | -18.8% |
CTMX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +100.2% | -23.5% | +53.1% |
| 5 y | 5-year | at high | +128.9% | -23.5% | +75.0% |
| alltime | all time | at high | +3637.1% | -23.5% | +990.0% |
CytomX Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $119.23 M(-16.5%) |
| Jun 2024 | - | $142.86 M(-1.2%) |
| Mar 2024 | - | $144.54 M(-7.3%) |
| Dec 2023 | $155.91 M(+2.2%) | $155.91 M(+6.2%) |
| Sep 2023 | - | $146.79 M(+3.8%) |
| Jun 2023 | - | $141.38 M(-6.5%) |
| Mar 2023 | - | $151.26 M(-0.9%) |
| Dec 2022 | $152.61 M(+96.0%) | $152.61 M(+56.0%) |
| Sep 2022 | - | $97.84 M(-1.6%) |
| Jun 2022 | - | $99.44 M(-3.2%) |
| Mar 2022 | - | $102.77 M(+32.0%) |
| Dec 2021 | $77.87 M(+14.3%) | $77.87 M(-22.0%) |
| Sep 2021 | - | $99.77 M(+6.8%) |
| Jun 2021 | - | $93.38 M(-4.8%) |
| Mar 2021 | - | $98.05 M(+44.0%) |
| Dec 2020 | $68.11 M(-20.4%) | $68.11 M(-33.2%) |
| Sep 2020 | - | $102.03 M(+3.3%) |
| Jun 2020 | - | $98.78 M(-6.8%) |
| Mar 2020 | - | $106.00 M(+23.8%) |
| Dec 2019 | $85.59 M | $85.59 M(+12.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $76.13 M(-3.2%) |
| Jun 2019 | - | $78.67 M(-18.2%) |
| Mar 2019 | - | $96.22 M(-1.7%) |
| Dec 2018 | $97.91 M(+60.1%) | $97.91 M(+13.5%) |
| Sep 2018 | - | $86.27 M(+3.7%) |
| Jun 2018 | - | $83.21 M(+19.4%) |
| Mar 2018 | - | $69.71 M(+14.0%) |
| Dec 2017 | $61.15 M(+71.0%) | $61.15 M(-14.2%) |
| Sep 2017 | - | $71.24 M(+17.5%) |
| Jun 2017 | - | $60.63 M(+63.3%) |
| Mar 2017 | - | $37.13 M(+3.8%) |
| Dec 2016 | $35.77 M(+127.3%) | $35.77 M(+51.0%) |
| Sep 2016 | - | $23.68 M(+6.6%) |
| Jun 2016 | - | $22.22 M(+30.7%) |
| Mar 2016 | - | $17.00 M(+8.0%) |
| Dec 2015 | $15.74 M(+41.0%) | $15.74 M(+12.6%) |
| Sep 2015 | - | $13.97 M(+27.7%) |
| Jun 2015 | - | $10.94 M(-2.0%) |
| Dec 2014 | $11.16 M(+167.6%) | $11.16 M |
| Dec 2013 | $4.17 M | - |
FAQ
- What is CytomX Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for CytomX Therapeutics?
- What is CytomX Therapeutics annual current liabilities year-on-year change?
- What is CytomX Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for CytomX Therapeutics?
- What is CytomX Therapeutics quarterly current liabilities year-on-year change?
What is CytomX Therapeutics annual total current liabilities?
The current annual current liabilities of CTMX is $155.91 M
What is the all time high annual current liabilities for CytomX Therapeutics?
CytomX Therapeutics all-time high annual total current liabilities is $155.91 M
What is CytomX Therapeutics annual current liabilities year-on-year change?
Over the past year, CTMX annual total current liabilities has changed by +$3.31 M (+2.17%)
What is CytomX Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of CTMX is $119.23 M
What is the all time high quarterly current liabilities for CytomX Therapeutics?
CytomX Therapeutics all-time high quarterly total current liabilities is $155.91 M
What is CytomX Therapeutics quarterly current liabilities year-on-year change?
Over the past year, CTMX quarterly total current liabilities has changed by -$27.56 M (-18.78%)